Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• A systematic review showing the lack of diagnostic criteria and tools developed for lower-limb cellulitis1 passage
• Alopecia areata and health-related quality of life: a systematic review and meta-analysis1 passage
• Atopic dermatitis: the skin barrier and beyond1 passage
• Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicentre, randomized, double-blinded, placebo-controlled trial1 passage
• Efficacy and safety of Cinainu in paediatric alopecia areata: an international, double-blind, randomized, placebo-controlled, phase II/III trial1 passage
• Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4)1 passage
• Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up)1 passage
• Genetic and environmental factors affecting hair density in East Asian populations1 passage
• Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial1 passage
• Risk factors for nonpurulent leg cellulitis: a systematic review and meta-analysis1 passage